Navigation Links
FDA-approved drug may slow beta cell destruction in type 1 diabetes patients
Date:12/4/2009

s of either rituximab or a placebo once a week for four weeks. The participants, who ranged in age from 8 to 40 years and had been diagnosed with type 1 diabetes within 100 days of enrollment in the study, returned approximately every three months for two years to undergo blood tests and meet with a physician. Two-thirds of the 81 participants received the drug.

The scientists found that after one year, the participants who received rituximab needed lower doses of insulin and were able to produce more of their own insulin than those who received the placebo. They also had better control of their blood sugar.

Dr. Raskin said researchers do not think rituximab could ever be used to completely reverse type 1 diabetes because the pancreas typically is too damaged by the time diabetes is diagnosed.

He also said that while the exact mechanism of how rituximab affects type 1 diabetes remains unclear, the study clearly shows that a therapy that targets B cells may improve beta-cell function in early type 1 diabetes.

The next step, Dr. Raskin said, is to evaluate the potential effects of rituximab in diabetes.


'/>"/>

Contact: Kristen Holland Shear
kristen.hollandshear@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
2. Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
3. IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide
4. Oregon Cosmetic Vein Center Opens in Portland, Among First on West Coast to Offer Brand New, FDA-Approved Procedures and Technologies
5. Edge Health Solutions Releases edgeDMS(TM) 2.0 and edgeMD 2.0(TM), Revolutionary All-in-One Practice Management Software with FDA-Approved Advanced Visualization
6. Newly Published Menopause Study: Bioidentical and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause
7. Grow Back Eyelashes - Orange County Plastic Surgeon Now Helps Patients Grow Longer, Fuller Darker Eyelashes With FDA-Approved Prescription Lash Treatment, Latisse
8. Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort
9. MultiVu Video Feed: SCIELE PHARMA ANNOUNCES AVAILABILITY OF ULESFIA(TM), FIRST AND ONLY FDA-APPROVED NON-NEUROTOXIC HEAD LICE TREATMENT
10. Introducing anuleaf AD, a New FDA-Approved Hemorrhoid Treatment
11. Upsher-Smith Launches New Website for Divigel(R), a Bioidentical and FDA-Approved Hormone Therapy for Moderate to Severe Hot Flashes, Including Night Sweats, Associated with Menopause
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA-approved drug may slow beta cell destruction in type 1 diabetes patients
(Date:8/30/2014)... HealthDay Reporter FRIDAY, Aug. ... operated on for broken bones or other orthopedic trauma shops ... Less-educated patients and patients who had used narcotic ... shoppers," said study lead author Dr. Brent Morris, a shoulder ... study suggests that doctors aren,t talking to one another about ...
(Date:8/30/2014)... Hastings and Hastings, a qualified team of knowledgeable ... pleased to report having saved a client $67,100 on ... cases where Hastings and Hastings has tailored its fees ... portion of their settlement or recovery. The firm has ... for Arizona car accident victims is achievable through dedicated ...
(Date:8/30/2014)... colchicine, a plant-based medication commonly used to treat ... results in reducing potential complications from this type ... of gastrointestinal adverse effects, according to a study ... being released early online to coincide with its ... , Common complications after cardiac surgery include postpericardiotomy ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 "My niece ... knowing that, at any moment, her fever might get ... to keep me well aware of how she was ... the TEMP ALARM to continuously monitor a child's temperature. ... a fever. This ensures that prompt medical care can ...
(Date:8/30/2014)... Bringing forth the great opportunities, India's #1 ... Day discount on all SEO services. While working with ... related to internet marketing. Their dedicated team of professionals ... have a deep understanding for their specialization. This further ... since the inception, they have worked with over 5000 ...
Breaking Medicine News(10 mins):Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2Health News:Medication shows mixed results in reducing complications from cardiac surgery 2Health News:Profit By Search Announces Labor Day Discount on SEO Services 2
... General Dynamics,Information Technology, a business unit of ... three task orders by the Defense Logistics Agency ... The,contracts have a total potential value of $7.4 ... Under these tasks, General Dynamics will provide ...
... , "Super paper:" New nanopaper more break-resistant than cast ... Japan report development of a new type of paper ... cast iron. The new material, called "cellulose nanopaper," is ... the way for expanded use of paper as a ...
... clinic rather than a consultant-led clinic for regular radiotherapy ... symptom management, according to a paper in the June ... And because the clinical nurse specialist was able to ... referring issues to the consultant, patients also avoided the ...
... and Chief,Operating Officer Matthew P. Cullen, 52, has been ... Bill Baer, president and,chief executive officer of The Crown ... YMCA does throughout the Metro Detroit,region- building strong kids, ... been a vital part of our great city for ...
... 9 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI; TSX:,QLT) ... subsidiary, has,entered into an asset purchase agreement with ... (NYSE: AGN ) to fully divest QLT,s,worldwide ... in,the United States and Canada for the treatment ...
... that will be presented on Monday at SLEEP 2008, ... Societies (APSS), finds that poor sleep is a problem ... by Julie L. Elam, of Indiana University, was based ... of 48 years. Seventy-six percent of the participants ...
Cached Medicine News:Health News:General Dynamics Awarded Multiple Contracts to Support Defense Medical Logistics Supply Chain Operations 2Health News:American Chemical Society's Weekly PressPac -- June 4, 2008 2Health News:American Chemical Society's Weekly PressPac -- June 4, 2008 3Health News:American Chemical Society's Weekly PressPac -- June 4, 2008 4Health News:American Chemical Society's Weekly PressPac -- June 4, 2008 5Health News:American Chemical Society's Weekly PressPac -- June 4, 2008 6Health News:American Chemical Society's Weekly PressPac -- June 4, 2008 7Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 2Health News:Specialist nurses can play a key role in supporting patients having radiotherapy 3Health News:Cullen Elected to Chairman of YMCA of Metro Detroit - the City's Oldest Not-for-Profit 2Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 2Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 3Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 4Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 5Health News:Poor sleep a problem in long-term breast cancer survivors 2
(Date:8/29/2014)... Research and Markets  has announced the addition of the ... to their offering. The Central Nervous System ... segments of pharmaceuticals industry. The numbers of CNS disorders have ... unable to meet the market requirements. There has been steady ... over the past two decades. The market for CNS therapies ...
(Date:8/29/2014)... Research and Markets has announced ... Forecast of Pharmaceutical Equipment Market in China, 2014-2018" ... Development Trend Forecast of Pharmaceutical Equipment Market in ... China,s pharmaceutical equipment industry in the aspects ... and business performance of domestic major enterprises, as well ...
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
... BD Beaver Clear Cornea Incision System ... specifically for the Cataract surgeon. The System ... an alternative to costly diamond knives. ... shield that is designed to both protects ...
... Built on the market leading optical ... 500 has been optimized for even better ... illumination system, including a new XHL Xenon ... the cornea and clear, high resolution images ...
The NIAGARA Thermal Retention System (TRS) maintains the temperature of prewarmed irrigation fluid continuously as it is delivered through the Corson®, Surgiflex® WAVE™, or Surgiflex D...
... the EZ Meter and press the measurement ... measurement results on its large color LCD ... printout makes this the ideal instrument for ... addition to being extremely easy-to-use, the EZ-200 ...
Medicine Products: